We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 64

1.21% more ownership

Funds ownership: 76.01% → 77.22% (+1.2%)

4% less funds holding

Funds holding: 215 → 207 (-8)

9% less capital invested

Capital invested by funds: $1.38B → $1.26B (-$121M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

46% less call options, than puts

Call options by funds: $6.35M | Put options by funds: $11.8M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
207
Holders Change
-8
Holders Change %
-3.72%
% of All Funds
4.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
86
Reduced
64
Closed
34
Calls
$6.35M
Puts
$11.8M
Net Calls
-$5.46M
Net Calls Change
+$11.4M

Top Buyers

1
BlackRock
BlackRock
New York
+$21.6M
2
ISL
Ingalls & Snyder LLC
New York
+$15.1M
3
Invesco
Invesco
Georgia
+$13.4M
4
Morgan Stanley
Morgan Stanley
New York
+$9.96M
5
Stifel Financial
Stifel Financial
Missouri
+$6.63M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$13.4M
3
JIM
Jupiter Investment Management
United Kingdom
-$7.9M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$6.89M
5
NC
Nexthera Capital
New York
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
DIA
51
Dana Investment Advisors
Wisconsin
$1.93M +$224K +16,057 +13%
TAM
52
Tealwood Asset Management
Minnesota
$1.9M -$11K -790 -0.6%
CS
53
Credit Suisse
Switzerland
$1.86M -$673K -48,146 -27%
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
$1.81M +$1.81M +129,290 New
Canada Life
55
Canada Life
Manitoba, Canada
$1.78M +$61.7K +4,413 +4%
Barclays
56
Barclays
United Kingdom
$1.74M +$1.2M +85,571 +223%
Marshall Wace
57
Marshall Wace
United Kingdom
$1.64M +$1.64M +117,252 New
JP Morgan Chase
58
JP Morgan Chase
New York
$1.56M +$617K +44,169 +66%
Los Angeles Capital Management
59
Los Angeles Capital Management
California
$1.53M +$690K +49,345 +83%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$1.52M -$1.64M -117,600 -52%
GC
61
Guggenheim Capital
Illinois
$1.5M +$255K +18,236 +21%
Citigroup
62
Citigroup
New York
$1.48M -$1.4M -100,526 -49%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$1.4M – – –
Russell Investments Group
64
Russell Investments Group
United Kingdom
$1.38M -$3.81M -272,971 -73%
DCM
65
Dupont Capital Management
Delaware
$1.3M – – –
PSUF
66
People's United Financial
Connecticut
$1.28M – – –
Comerica Bank
67
Comerica Bank
Texas
$1.25M -$577K -41,264 -29%
TCM
68
Tanaka Capital Management
New York
$1.24M – – –
ECM
69
ETrade Capital Management
Virginia
$1.2M +$245K +17,499 +26%
SIA
70
Sit Investment Associates
Minnesota
$1.1M -$240K -17,200 -18%
AIG
71
American International Group
New York
$1.09M +$37.1K +2,656 +4%
First Trust Advisors
72
First Trust Advisors
Illinois
$1.07M +$34.3K +2,456 +3%
Public Sector Pension Investment Board (PSP Investments)
73
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.03M +$163K +11,645 +19%
Thrivent Financial for Lutherans
74
Thrivent Financial for Lutherans
Minnesota
$1.01M +$89.8K +6,429 +10%
VOYA Investment Management
75
VOYA Investment Management
Georgia
$1.01M – – –
1 2
3
4 5

CORT Hedge Fund Activity: Q3 2018 in Review

207 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2018, worth a combined $1.26B — down 8.8% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of CORT and 27 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 86 added.

The largest buyer was BlackRock, adding an estimated $21.6M. The largest seller was Acadian Asset Management, cutting an estimated $19M.

  • 207 institutional investors held Corcept Therapeutics (CORT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.26B of Corcept Therapeutics stock for Q3 2018, down 8.8% quarter-over-quarter.
  • 27 funds opened new Corcept Therapeutics positions in Q3 2018 and 34 closed out, a net change of -7 holders.
  • The largest Corcept Therapeutics buyer in Q3 2018 was BlackRock, an estimated $21.6M added.
  • The largest Corcept Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q3 2018.